Role of the cyclic-AMP/PKA cascade and of P/Q-type Ca++ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens

Neuropharmacology. 2008 Jan;54(1):87-94. doi: 10.1016/j.neuropharm.2007.04.014. Epub 2007 May 5.

Abstract

Glutamate transmission between prefrontal cortex (PFC) and accumbens (NAc) plays a crucial role in the establishment and expression of addictive behaviors. At these synapses exogenous cannabinoid receptor 1 (CB1R) agonists reversibly inhibit excitatory transmission, and the sustained release of endogenous cannabinoids (eCB) following prolonged cortical stimulation leads to long-term depression (LTD). Activation of presynaptic K(+) channels mediates the effects of exocannabinoids, but the transduction pathway underlying the protracted phase of eCB-LTD is unknown. Here we report that the maintenance of eCB-LTD does not involve presynaptic K(+) channels: eCB-LTD was not affected by blockade of K(+) channels with 4-AP (100 microM) and BaCl(2) (300 microM) (fEPSP=78.9+/-5.4% of baseline 58-60 min after tetanus, compared to 78.9+/-5.9% in control slices). In contrast, eCB-LTD was blocked by treatment of the slices with the adenylyl cyclase (AC) activator forskolin (10 microM), and with the protein kinase A (PKA) inhibitor KT5720 (1 microM) (fEPSP=108.9+/-5.7% in forskolin and 110.5+/-7.7% in KT5720, compared to 80.6+/-3.9% in control conditions). Additionally, selective blockade of P/Q-type Ca(2+) channels with omega-agatoxin-IVA (200 nM) occluded the expression of eCB-LTD (fEPSP=113.4+/-15.9% compared to 78.6+/-4.4% in control slices), while blockade of N- with omega-conotoxin-GVIA (1 microM) or L-type Ca(2+) channels with nimodipine (1 microM), was without effect (fEPSP was 83.7+/-5.3% and 87+/-8.9% respectively). These data show that protracted inhibition of AC/PKA activity and P/Q-type Ca(2+) channels are necessary for expression of eCB-LTD at NAc synapses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Aminopyridine / pharmacology
  • Action Potentials / drug effects
  • Action Potentials / physiology
  • Action Potentials / radiation effects
  • Animals
  • Barium Compounds / pharmacology
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, P-Type / physiology*
  • Cannabinoid Receptor Modulators / antagonists & inhibitors
  • Cannabinoid Receptor Modulators / metabolism*
  • Carbazoles / pharmacology
  • Chlorides / pharmacology
  • Colforsin / pharmacology
  • Cyclic AMP / metabolism*
  • Electric Stimulation / methods
  • Endocannabinoids*
  • Enzyme Inhibitors / pharmacology
  • In Vitro Techniques
  • Indoles / pharmacology
  • Long-Term Synaptic Depression / drug effects
  • Long-Term Synaptic Depression / physiology*
  • Long-Term Synaptic Depression / radiation effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nucleus Accumbens / drug effects
  • Nucleus Accumbens / physiology*
  • Patch-Clamp Techniques / methods
  • Potassium Channel Blockers / pharmacology
  • Pyrroles / pharmacology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology

Substances

  • Barium Compounds
  • Calcium Channel Blockers
  • Calcium Channels, P-Type
  • Cannabinoid Receptor Modulators
  • Carbazoles
  • Chlorides
  • Endocannabinoids
  • Enzyme Inhibitors
  • Indoles
  • Potassium Channel Blockers
  • Pyrroles
  • barium chloride
  • Colforsin
  • KT 5720
  • 4-Aminopyridine
  • Cyclic AMP
  • Calcium